GRPN: the little company that could
GRPN is my biggest holding. I think they are pulling off one of the best business turnarounds we have seen in the past decade and the market is dead asleep on it. Am I regarded? Read and decide for yourself. …
GRPN is my biggest holding. I think they are pulling off one of the best business turnarounds we have seen in the past decade and the market is dead asleep on it. Am I regarded? Read and decide for yourself. …
I’ve tried long, short, spreads, nakeds and everything on betweeen. I did find a strategy that is the tiniest bit profitable, I’m talking super small. Like trading the same strategy with one contract every single day would net you maybe …
I’ve been reading about the LIME (Neutron Holdings) IPO available on July 1st for $24-$26 a share and was thinking about applying for a few shares. I was reading about how they’ve been partnering with Uber with the electric scooters, …
This is the last step to completing the mainstream adoption to squeeze WEN like no tomorrow one of you 5-star generals who has thousands of shares needs to be our leader and stream the DD and discussion around WEN for …
I have been following AMPX for some time now and it feels like one of those stocks where the actual company progress has been pretty damn good, but the chart still manages to make you feel like you’re missing something. …
Last Friday I had a successful day day trading options on SPY. Scalping. Today, not so much: the runners kept on running on my puts and things didn’t feel as predictable today as when I did on Friday. Genuinely, SPY …
Good News here: # Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease BETHESDA, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a …
I've seen people on the sub say if you're currently holding WBD stock valued at $27, it's not worth it to hold onto it for another year, because the upside is a potential 10% or so return and the downside …